Trials / Completed
CompletedNCT02925338
National Observational Study On The Use Of Inflectra™ An Infliximab Biosimilar In Real Life
OBSERVATOIRE NATIONAL D'UTILISATION D'INFLECTRA™ EN VIE RÉELLE.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 1,431 (actual)
- Sponsor
- Pfizer · Industry
- Sex
- All
- Age
- 6 Years
- Healthy volunteers
- Not accepted
Summary
National, prospective, multicentre observational study designed for eligible patients treated with Inflectra. Its objectives are to describe under real conditions of use, the profile of patients treated with Inflectra and the response to treatment.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | QOL questionaire | Health assessment questionnaire disability index for rheumatoid polyarthritis questionnaire |
Timeline
- Start date
- 2016-10-19
- Primary completion
- 2021-04-12
- Completion
- 2021-04-12
- First posted
- 2016-10-05
- Last updated
- 2023-01-25
- Results posted
- 2023-01-25
Locations
67 sites across 1 country: France
Source: ClinicalTrials.gov record NCT02925338. Inclusion in this directory is not an endorsement.